SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-008537
Filing Date
2024-03-19
Accepted
2024-03-19 16:31:16
Documents
18
Period of Report
2024-03-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240318_8k.htm   iXBRL 8-K 30688
2 EXHIBIT 3.1 ex_641760.htm EX-3.1 6449
3 EXHIBIT 99.1 ex_640955.htm EX-99.1 8867
8 a01.jpg GRAPHIC 5090
9 logo.jpg GRAPHIC 5546
  Complete submission text file 0001437749-24-008537.txt   210826

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240319.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240319_def.xml EX-101.DEF 11804
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240319_lab.xml EX-101.LAB 15848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240319_pre.xml EX-101.PRE 12019
21 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240318_8k_htm.xml XML 2942
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 24763900
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)